Delivery Order SPE2DR25D1202-SPE2DR26F72DR
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,254.76 for 30 tablets of Movantik 25 mg on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located in Conshohocken, Pennsylvania,...
- This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency awarded a $3,514.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the 25 mg Movantik medication. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by August 14, 2023 to support DLA's medical supply needs. No subcontractors or set aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET 30S. The contract has a firm fixed price of $1,177.53 and a completion date of June 27, 2025. The contract is not set aside and was awarded on June 26, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET UD 100S. The delivery order, valued at $4,908.94, is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to support military treatment...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. This $1,015 order is to supply 100 tablets of the 25mg Movantik medication to the agency's place of performance in Conshohocken, Pennsylvania by October 26, 2023. No set-aside designation was applied to this order, which is for the delivery of a specified pharmaceutical product to support DLA's medical treatment...
- This delivery order for seven hundred twenty-six dollars was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, for the delivery of 4562539420 MOVANTIK 25 MG TABLET 30S. The order has a firm fixed price and completion date of October 20, 2023. No set-aside designation was used for this award placed against an existing vehicle by the Defense Logistics Agency Troop Support Medical to support its medical supply...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,531.81. The contract is a firm fixed price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,956.67 firm fixed-price delivery order is for the supply of MOVANTIK 25 MG TABLET UD 100S, a pharmaceutical product, with a completion date of January 29, 2024. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, with a ceiling value of $5,397.18, is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 25, 2023. The award is not designated under any set-aside program, indicating open competition....
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72DRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,315.07 to AmerisourceBergen Drug Corp for 30 tablets of Movantik 12.5 mg on November 13, 2025, with completion scheduled for November 14, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a transactional order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability in fulfilling federal medical procurement requirements across multiple therapeutic domains has positioned it as a critical vendor for military and veteran healthcare systems under the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/13/25 |